Michael V.

At a venture capital firm focused on neurotechnology and MedTech, I lead scientific and technical due diligence for early-stage investments across clinical and consumer applications and proactively scout emerging technologies, platforms, and teams across the innovation ecosystem. I evaluate opportunities for scientific validity, differentiation, translational risk, and strategic fit, informing go/no-go decisions and portfolio prioritization. My work integrates market, competitive, IP, and clinic

Pre-clinical development of novel biodegradable orthopaedic implants. Planning and execution of studies based on scientific research, regulatory requirements, and company milestones. Oversight of the CROs and third-party vendors, overall accountability for the successful execution from protocol concept to study results analysis, reporting and regulatory filing. Managing and tracking the full scope of study activities, timelines, and budget.

Pre-clinical development of urological drug device combination.

Developing novel neurogenerative and neuroprotective treatment based on CSF continues exchange. Initiation, direction and execution of scientific research. Feasibility investigation of applying a wide variety of scientific principles and concepts to potential inventions, products and problems. Planning and execution of laboratory research.

Consulting on research strategy, study planning and execution, and results analysis and interpretation of various in-vitro, ex-vivo and in-vivo studies, including physiological, pharmacokinetic and pharmacological aspects.

Teaching assistant, the School of Pharmacy and the School of Medicine: Systems Physiology, Pharmacology, Pharmacokinetics.

Supported asset-side strategy for CNS therapeutics, contributing to in-licensing, partnering, and internal portfolio prioritization across neurology and psychiatry programs. Conducted an early-stage evaluation of assets and mechanisms, assessing scientific rationale, translational feasibility, differentiation, and development risk. Built and applied structured evaluation frameworks, including MoA analysis, gap assessment, and competitive positioning, to support business development and pipeline